hexoprenaline has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Islami, H | 1 |
| Veseli, A | 1 |
| Behluli, E | 1 |
| Morina, N | 1 |
1 other study available for hexoprenaline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Importance of the adrenergic nerve system in the response of gases in the arterial blood following the provoked bronchospasm.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Adul | 2012 |